Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

China flag China · Delayed Price · Currency is CNY
9.49
-0.03 (-0.32%)
Apr 28, 2026, 3:04 PM CST
Market Cap3.79B -3.3%
Revenue (ttm)1.52B -11.6%
Net Income-69.52M
EPS-0.17
Shares Out398.52M
PE Ration/a
Forward PEn/a
Dividend0.20 (2.11%)
Ex-Dividend Daten/a
Volume6,115,842
Average Volume5,214,319
Open9.43
Previous Close9.52
Day's Range9.42 - 9.73
52-Week Range8.70 - 14.55
Beta0.60
RSI39.72
Earnings DateApr 29, 2026

About SHE:301060

Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing; and professional technical support services. In addition, the company offers rental, business, and human resources services. Further, it operates Lan... [Read more]

Sector Healthcare
Founded 1993
Employees 1,365
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301060
Full Company Profile

Financial Performance

In 2024, SHE:301060's revenue was 1.74 billion, an increase of 4.05% compared to the previous year's 1.67 billion. Losses were -109.44 million, -22.71% less than in 2023.

Financial Statements